Literature DB >> 2599990

An increase in the antimicrobial activity in vitro of fosfomycin under anaerobic conditions.

S Inouye1, T Watanabe, T Tsuruoka, I Kitasato.   

Abstract

Fosfomycin showed lower MIC values under anaerobic culture conditions than those under aerobic conditions for four Gram-positive and 18 Gram-negative bacterial isolates. The degree of change in MICs was dependent on the culture media and strains tested. The growth-inhibitory diameter in the paper disc assay increased in parallel with the decrease in the redox potential of the agar medium. Bacteriolytic activity was also potentiated in anaerobiosis. The increase of the bio-activity of fosfomycin in anaerobic culture was neither due to the change of medium pH nor to the change of mobility of drug in agar. However it is possible that the uptake of fosfomycin through the cell membrane increased in anaerobiosis. The anaerobic MICs of fosfomycin were better correlated than the aerobic MICs with the ED50 values in a mouse systemic infection model.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2599990     DOI: 10.1093/jac/24.5.657

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  13 in total

1.  Antibiotic abscess penetration: fosfomycin levels measured in pus and simulated concentration-time profiles.

Authors:  Robert Sauermann; Rudolf Karch; Herbert Langenberger; Joachim Kettenbach; Bernhard Mayer-Helm; Martina Petsch; Claudia Wagner; Thomas Sautner; Rainer Gattringer; Georgios Karanikas; Christian Joukhadar
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

2.  The influence of anaerobiosis on the activity of fosfomycin trometamol.

Authors:  D Greenwood; J Brown; R Edwards
Journal:  Infection       Date:  1992       Impact factor: 3.553

3.  Eradication of Pseudomonas aeruginosa biofilms on cultured airway cells by a fosfomycin/tobramycin antibiotic combination.

Authors:  Gregory G Anderson; Thomas F Kenney; David L Macleod; Noreen R Henig; George A O'Toole
Journal:  Pathog Dis       Date:  2013-01-10       Impact factor: 3.166

Review 4.  Fosfomycin.

Authors:  Matthew E Falagas; Evridiki K Vouloumanou; George Samonis; Konstantinos Z Vardakas
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

Review 5.  Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections.

Authors:  S S Patel; J A Balfour; H M Bryson
Journal:  Drugs       Date:  1997-04       Impact factor: 9.546

6.  Fosfomycin/tobramycin for inhalation in patients with cystic fibrosis with pseudomonas airway infection.

Authors:  Bruce C Trapnell; Susanna A McColley; Dana G Kissner; Mark W Rolfe; Jonathan M Rosen; Matthew McKevitt; Lisa Moorehead; A Bruce Montgomery; David E Geller
Journal:  Am J Respir Crit Care Med       Date:  2011-11-17       Impact factor: 21.405

7.  Structural and functional characterization of fosfomycin resistance conferred by FosB from Enterococcus faecium.

Authors:  Vanessa Wiltsie; Skye Travis; Madeline R Shay; Zachary Simmons; Patrick Frantom; Matthew K Thompson
Journal:  Protein Sci       Date:  2021-12-22       Impact factor: 6.725

8.  Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin.

Authors:  M E Falagas; M D Kanellopoulou; D E Karageorgopoulos; G Dimopoulos; P I Rafailidis; N D Skarmoutsou; E A Papafrangas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-23       Impact factor: 3.267

9.  Elevated Expression of GlpT and UhpT via FNR Activation Contributes to Increased Fosfomycin Susceptibility in Escherichia coli under Anaerobic Conditions.

Authors:  Kumiko Kurabayashi; Koichi Tanimoto; Shinobu Fueki; Haruyoshi Tomita; Hidetada Hirakawa
Journal:  Antimicrob Agents Chemother       Date:  2015-07-27       Impact factor: 5.191

Review 10.  Fosfomycin: Uses and potentialities in veterinary medicine.

Authors:  D S Pérez; M O Tapia; A L Soraci
Journal:  Open Vet J       Date:  2014-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.